A 69-year-old with T2DM and CKD asks about GLP-1 RA vs SGLT2i. Which statement is correct per ADA?...

Question

A 69-year-old with T2DM and CKD asks about GLP-1 RA vs SGLT2i. Which statement is correct per ADA?

Accepted Answer

SGLT2 inhibitors reduce CKD progression and HF events; GLP-1 RAs reduce ASCVD events-both may be indicated

Answer

ASCVD

Answer

and CKD asks about GLP-1 RA vs SGLT2i. Which statement is correct per ADA?

Answer

Only GLP-1 RAs have CV benefits

Answer

Only SGLT2i reduce ASCVD events

ukmla MCQ (SBA): Type 2 Diabetes Mellitus